The safety of performing breast reconstruction during the COVID-19 pandemic.
Breast Cancer
; 29(2): 242-246, 2022 Mar.
Article
in English
| MEDLINE | ID: covidwho-1469776
ABSTRACT
PURPOSE:
Elective operations including surgeries for breast cancer were significantly reduced during the height of the surge of COVID-19 cases in Massachusetts. The safety of performing breast reconstruction during the pandemic was unknown. This study aims to review the safety of performing mastectomy with immediate breast reconstruction during the first COVID-19 surge in Massachusetts.METHODS:
A retrospective chart review of patients who underwent mastectomy with immediate breast reconstruction by Massachusetts General Hospital breast and plastic surgeons immediately preceding and during the COVID-19 pandemic was performed.RESULTS:
Thirty patients (34 breasts) underwent mastectomies with immediate breast reconstruction during the COVID-19 restriction period in Massachusetts. Most reconstructions were unilateral. All reconstructions were performed with implants or expanders, and no autologous reconstructions were performed. Two patients (2 breasts) had operative complications. The complication rate during the pandemic was similar to the complication rate pre-pandemic. No patients or surgeons experienced symptoms or positive COVID-19 tests. Over 90% of patients were discharged the same day.CONCLUSION:
Prosthetic breast reconstruction was able to be performed safely during the height of the COVID-19 pandemic surge in Massachusetts. Strict screening protocols, proper use of personal protective equipment, and same-day discharge when possible are essential for patient and surgeon safety during the pandemic.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Mammaplasty
/
Breast Implants
/
COVID-19
Type of study:
Observational study
Topics:
Long Covid
Limits:
Female
/
Humans
Language:
English
Journal:
Breast Cancer
Journal subject:
Neoplasms
Year:
2022
Document Type:
Article
Affiliation country:
S12282-021-01304-2
Similar
MEDLINE
...
LILACS
LIS